[Federal Register Volume 77, Number 111 (Friday, June 8, 2012)]
[Notices]
[Pages 34072-34073]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-13919]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Rhodes Technologies

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 1, 2012, Rhodes 
Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made 
application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of

[[Page 34073]]

Morphine (9300), a basic class of controlled substance listed in 
schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for conversion and sale to dosage form manufacturers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 7, 2012.

     Dated: May 31, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control. Drug 
Enforcement Administration.
[FR Doc. 2012-13919 Filed 6-7-12; 8:45 am]
BILLING CODE 4410-09-P